NDC 51672-4037-01 - Enalapril Maleate
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 51672-4037
- Requested NDC
- 51672-4037-01
- Package NDCs from labels
- 51672-4037-1, 51672-4037-3, 51672-4037-01
- Manufacturer
- Bryant Ranch Prepack
- Effective date
- 2026-08-20
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Enalapril Maleate - Bryant Ranch Prepack | Bryant Ranch Prepack | 2026-08-20 | HUMAN PRESCRIPTION DRUG LABEL |
| Enalapril Maleate - Bryant Ranch Prepack | Bryant Ranch Prepack | 2026-08-11 | HUMAN PRESCRIPTION DRUG LABEL |
| Enalapril Maleate Tablets, USP | Golden State Medical Supply, Inc. | 2026-08-05 | HUMAN PRESCRIPTION DRUG LABEL |
| Enalapril Maleate Tablets, USP | Sun Pharmaceutical Industries, Inc. | Taro Pharmaceuticals Industries Ltd. | 2026-07-14 | HUMAN PRESCRIPTION DRUG LABEL |
| Enalapril Maleate Tablets, USP | REMEDYREPACK INC. | 2025-06-11 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 51672-4037-1 | Enalapril Maleate | 100 in 1 BOTTLE | TABLET | 100 | 13 | |
| 51672-4037-3 | Enalapril Maleate | 1000 in 1 BOTTLE | TABLET | 1000 | 13 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 51672-4037 | ENALAPRIL MALEATE TABLET [TARO PHARMACEUTICALS U.S.A., INC.] | 13 | Current NDC, Legacy NDC, 2 package rows | 20230728_f103b9f9-e081-419d-a2d8-b86acda834dd.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 51672-4037-1 | EA - Each | 51672-4037 | eb541e3e-61c9-4535-a290-3a07a8b5a784 | 1 | 2013-02-13 |
| 51672-4037-3 | EA - Each | 51672-4037 | 4e882282-ab47-4444-b1bf-bf96a9fca925 | 1 | 2013-02-13 |
DailyMed Socrata Ingredients#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Enalapril Maleate | ENALAPRIL MALEATE | A-S Medication Solutions | f3754f29-9b75-4e2c-9c28-b3479f5bf906 | 2023-10-02 | Boxed warning, Warnings, Adverse reactions | ANDA075657 858817 9O25354EPJ |
| Omeprazole/Sodium Bicarbonate | OMEPRAZOLE | Strides Pharma Science Limited | cf6d293e-d70d-443e-8292-d693e93aab55 | 2023-09-21 | Warnings, Adverse reactions | 8MDF5V39QO |
| Sodium Bicarbonate | SODIUM BICARBONATE | OMNIVIUM PHARMACEUTICALS LLC. | aea54f8d-1cdd-4a5c-a2f7-7317ae4c8fbc | 2023-08-10 | Warnings, Adverse reactions | 8MDF5V39QO |
| ZEGERID | OMEPRAZOLE AND SODIUM BICARBONATE | Santarus, Inc.. | cd6868b9-5824-442b-8d65-4db29ecb70a4 | 2023-07-19 | Warnings, Adverse reactions | 8MDF5V39QO |
| Omeprazole and Sodium Bicarbonate | OMEPRAZOLE AND SODIUM BICARBONATE | Dr. Reddy's Laboratories Inc., | c6b5f808-4a49-1303-9711-badb022ecd70 | 2023-07-19 | Warnings | 8MDF5V39QO |
| Sodium Bicarbonate | SODIUM BICARBONATE | A-S Medication Solutions | 619cb558-84e5-43ea-91e9-28c764f9f9c0 | 2023-06-21 | Warnings, Adverse reactions | 8MDF5V39QO |
| PEG-3350 and Electrolytes | POLYETHYLENE GLYCOL 3350, SODIUM SULFATE ANHYDROUS, SODIUM BICARBONATE, SODIUM CHLORIDE, POTASSIUM CHLORIDE | A-S Medication Solutions | 7a2d8dab-750f-43c1-933c-4169a840c60c | 2023-06-20 | Warnings, Adverse reactions | 8MDF5V39QO |
| Enalapril Maleate | ENALAPRIL MALEATE | A-S Medication Solutions | 7b80abb4-fa75-48a4-a2e9-b0e31205234c | 2023-05-23 | Boxed warning, Warnings, Adverse reactions | 858813 9O25354EPJ |
| Sodium Bicarbonate | SODIUM BICARBONATE | Medical Purchasing Solutions, LLC | b620938d-ab2d-0934-e053-2a95a90a8483 | 2023-05-23 | Warnings, Adverse reactions | 8MDF5V39QO |
| Sodium Bicarbonate | SODIUM BICARBONATE | Medical Purchasing Solutions, LLC | d1636b56-ad83-4439-e053-2a95a90a135e | 2023-05-02 | Warnings, Adverse reactions | 8MDF5V39QO |
| Enalapril maleate | ENALAPRIL MALEATE | A-S Medication Solutions | ccdd0f67-e9d5-41e3-93d5-94b9792a6f8f | 2023-04-27 | Warnings, Adverse reactions | 858810 9O25354EPJ |
| Ferrum Oxydatum | FERRUM OXYDATUM | Hahnemann Laboratories, INC. | f8b52d3f-3fe2-a850-e053-6394a90a5d9f | 2023-04-06 | 1K09F3G675 | |
| POLYETHYLENE GLYCOL-3350 AND ELECTROLYTES | POLYETHYLENE GLYCOL-3350 AND ELECTROLYTES | Novel Laboratories, Inc. | 29d821ff-389c-41fb-8a27-89bd3f022b82 | 2023-02-08 | Warnings, Adverse reactions | 8MDF5V39QO |
| Omeprazole, Sodium bicarbonate | OMEPRAZOLE, SODIUM BICARBONATE | Guardian Drug Company | e5c6c2cf-fb3b-456a-a0a0-be396d6f8319 | 2022-11-08 | Warnings, Adverse reactions | 8MDF5V39QO |
| Enalapril maleate oral solution | ENALAPRIL MALEATE | Camber Pharmaceuticals, Inc. | b63bdaa6-b57b-417b-9a79-29f1fd5bbf08 | 2022-02-10 | Boxed warning, Warnings, Adverse reactions | 9O25354EPJ |
| Sodium Bicarbonate | SODIUM BICARBONATE | International Medication Systems, Limited | 77698221-a01d-4568-a7bc-d3d4e982875d | 2021-12-15 | Warnings, Adverse reactions | 8MDF5V39QO |
| 8.4% SODIUM BICARBONATE | 8.4% SODIUM BICARBONATE | HF Acquisition Co. LLC, DBA HealthFirst | 74d8bb7a-9e7a-105f-e053-2a91aa0aec92 | 2021-05-03 | Warnings, Adverse reactions | 8MDF5V39QO |
| SODIUM BICARBONATE | SODIUM BICARBONATE | Medical Purchasing Solutions, LLC | bfc9c321-665c-ca97-e053-2995a90a7954 | 2021-04-12 | Warnings, Adverse reactions | 8MDF5V39QO |
| Enalapril Maleate | ENALAPRIL MALEATE | OCEANSIDE PHARMACEUTICALS | ebd2a62d-a704-4f8a-a104-749a5296502f | 2020-12-01 | Boxed warning, Warnings, Adverse reactions | 858804 858810 858817 858813 9O25354EPJ |
| Vaseretic | ENALAPRIL MALEATE AND HYDROCHLOROTHIAZIDE | Bausch Health US, LLC | bf3007e2-8fcc-48de-8fd5-55e95033d62f | 2020-08-31 | Boxed warning, Warnings, Adverse reactions | 9O25354EPJ |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.